💨 Abstract

Agios Pharmaceuticals Inc. reported a Q1 loss of $89.3 million, beating analyst expectations with a loss of $1.55 per share. However, revenue of $8.7 million was lower than forecasted, and the company's shares have dropped nearly 10% since the beginning of the year, down almost 9% in the last 12 months.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖